EE9500076A - 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena - Google Patents

1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena

Info

Publication number
EE9500076A
EE9500076A EE9500076A EE9500076A EE9500076A EE 9500076 A EE9500076 A EE 9500076A EE 9500076 A EE9500076 A EE 9500076A EE 9500076 A EE9500076 A EE 9500076A EE 9500076 A EE9500076 A EE 9500076A
Authority
EE
Estonia
Prior art keywords
dihydropyridines
medicaments
bridged
ch2ch2ch2
ch2ch
Prior art date
Application number
EE9500076A
Other languages
English (en)
Estonian (et)
Inventor
Urbahns Klaus
Heine Hans-Georg
Junge Bodo
Glaser Thomas
Wittka Reilinde
De Vry Jean-Marie-Viktor
Sommermeyer Henning
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE9500076A publication Critical patent/EE9500076A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9500076A 1994-12-16 1995-12-15 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena EE9500076A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4444860A DE4444860A1 (de) 1994-12-16 1994-12-16 Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als Arzneimittel

Publications (1)

Publication Number Publication Date
EE9500076A true EE9500076A (et) 1996-06-17

Family

ID=6535985

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9500076A EE9500076A (et) 1994-12-16 1995-12-15 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena

Country Status (25)

Country Link
US (2) US5990121A (fi)
EP (2) EP0717043B1 (fi)
JP (1) JPH08239384A (fi)
KR (1) KR960022517A (fi)
CN (1) CN1059442C (fi)
AT (1) ATE186536T1 (fi)
AU (1) AU709760B2 (fi)
CA (1) CA2165131A1 (fi)
CZ (1) CZ332895A3 (fi)
DE (2) DE4444860A1 (fi)
DK (1) DK0717043T3 (fi)
EE (1) EE9500076A (fi)
ES (1) ES2139824T3 (fi)
FI (1) FI956016A (fi)
GR (1) GR3032394T3 (fi)
HU (1) HUT74166A (fi)
IL (1) IL116386A (fi)
MX (1) MX9505097A (fi)
NO (1) NO955103L (fi)
NZ (1) NZ280661A (fi)
PL (1) PL180439B1 (fi)
RU (1) RU2155765C2 (fi)
SI (1) SI0717043T1 (fi)
SK (1) SK158095A3 (fi)
ZA (1) ZA9510695B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
US7394475B2 (en) * 2004-02-13 2008-07-01 Infoprint Solutions Company, Llc Apparatus, system, and method for image registration
DE602005023489D1 (de) * 2004-06-23 2010-10-21 Neurotec Pharma S L Zusammensetzung zur verwendung bei diagnose der akuten verletzungen des zentralen nervensystems
WO2006000607A1 (es) * 2004-06-23 2006-01-05 Neurotec Pharma, S.L. Uso de activadores de los canales de katp (kco), en particular el diazóxido, en el tratamiento de la inflamación crónica de snc asociada a algunas efermedades
AU2006203819A1 (en) * 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE220633C (fi) *
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3951988A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 1,2-Pentamethylene-1,4-dihydropyridine derivatives
US4053614A (en) * 1972-03-06 1977-10-11 Bayer Aktiengesellschaft 1,2-pentamethylene-1,4-dihydropyridine derivatives
DE2210633C2 (de) * 1972-03-06 1983-09-22 Bayer Ag, 5090 Leverkusen Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US3935220A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft Tetrahydroimidazolo[1,2-a]pyridine derivatives
US5225566A (en) * 1992-05-08 1993-07-06 American Home Products Corporation Indazolanonyl derivative of benzopyran

Also Published As

Publication number Publication date
EP0924211A3 (de) 1999-07-07
JPH08239384A (ja) 1996-09-17
ATE186536T1 (de) 1999-11-15
PL311843A1 (en) 1996-06-24
FI956016A (fi) 1996-06-17
ZA9510695B (en) 1996-07-03
EP0717043B1 (de) 1999-11-10
GR3032394T3 (en) 2000-05-31
RU2155765C2 (ru) 2000-09-10
SI0717043T1 (en) 2000-02-29
AU709760B2 (en) 1999-09-09
CN1133841A (zh) 1996-10-23
US6147087A (en) 2000-11-14
CA2165131A1 (en) 1996-06-17
KR960022517A (ko) 1996-07-18
AU4029495A (en) 1996-06-27
NO955103L (no) 1996-06-17
NZ280661A (en) 1997-06-24
SK158095A3 (en) 1996-09-04
EP0924211A2 (de) 1999-06-23
MX9505097A (es) 1997-01-31
CN1059442C (zh) 2000-12-13
IL116386A (en) 1999-06-20
DE4444860A1 (de) 1996-06-20
FI956016A0 (fi) 1995-12-14
HUT74166A (en) 1996-11-28
PL180439B1 (pl) 2001-02-28
DE59507220D1 (de) 1999-12-16
NO955103D0 (no) 1995-12-15
IL116386A0 (en) 1996-03-31
EP0717043A1 (de) 1996-06-19
ES2139824T3 (es) 2000-02-16
DK0717043T3 (da) 2000-05-08
US5990121A (en) 1999-11-23
CZ332895A3 (en) 1997-12-17
HU9503597D0 (en) 1996-02-28

Similar Documents

Publication Publication Date Title
DK0390654T3 (da) Aminobenzensulfonsyrederivater
DE69010100D1 (de) Pyrimidinyl herbizides Mittel.
DK705888A (da) Pyridazinonderivater
DE69434198D1 (de) Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten
EE9500076A (et) 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena
DK0737678T3 (da) 4-Indolylpiperazinyl-derivater
EE9500075A (et) 5-atsüül-1,4-dihüdropüridiinide kasutamine
DE69017774D1 (de) Benzothiazol-derivate als fungizide.
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
NO963374D0 (no) Substituerte 4H-pyraner
DE69607597T2 (de) Benzol-derivate
ATE97409T1 (de) Benzodiazepin-analoge.
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE195936T1 (de) Bis-imide derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung
FI101071B (fi) Menetelmä terapeuttisesti käyttökelpoisten 3,4-dihydroisokinoliini-N-o ksidien valmistamiseksi
ES2059928T3 (es) Ciclopropanotiocarboxiamidas.
FI942265A0 (fi) 2-aminopyratsin-5-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö